Peter Lay
businessMale0.0Global Dominance: 0.00%
Peter Lay is the director of New Business at Teuto, overseeing the introduction of new generic products to the market, with a focus on cardiovascular medications and managing a substantial backlog of products awaiting regulatory approval.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Peter Lay, director of Novos Negócios at Teuto, discusses the laboratory's plans for new medications.
Indústria já prepara genérico do Ozempic, mas fabricante tenta prorrogar patente na Justiça. Entenda o imbróglioO Globo·
Brazil· 2025-08-18
Brazil· 2025-08-18
Peter Lay, director of New Business at Teuto, shares that the laboratory has 80 products awaiting Anvisa approval.
veja como a indústria se preparaO Globo·Brazil· 2025-08-17
Brazil· 2025-08-17
Peter Lay is the director of New Business at Teuto.
veja como a indústria se preparaO Globo·Brazil· 2025-08-17
Brazil· 2025-08-17